NCT05697718View on ClinicalTrials.gov

Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

July 29, 2024

Study Completion Date

August 27, 2024

Conditions

Ischemic Stroke

Interventions

BIOLOGICAL

MSC

a single injection dose i.v.

Trial Locations (2)

Unknown

Xuanwu Hospital of Capital Medical University, Beijing

Xuanwu Hospital of Capital Medical University, Beijing

All Listed Sponsors

lead

Shanghai IxCell Biotechnology Co., LTD

OTHER